UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1154-1161

2017

Volltextzugriff (PDF)

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Blood, 2014-06, Vol.123 (23), p.3664-3671

2014

Volltextzugriff (PDF)

Clash of the titans: axi-cel versus tisa-cel for advanced-stage DLBCL

Nature reviews. Clinical oncology, 2023-01, Vol.20 (1), p.5-6

2023

Volltextzugriff (PDF)

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

The New England journal of medicine, 2019-01, Vol.380 (1), p.45-56

2019

Volltextzugriff (PDF)

Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002056

2021

Volltextzugriff (PDF)

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

The New England journal of medicine, 2022-02, Vol.386 (7), p.629-639

2022

Volltextzugriff (PDF)

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4767-4773

2009

Volltextzugriff (PDF)

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1273-1283

2020

Volltextzugriff (PDF)

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3249-3256

2014

Volltextzugriff (PDF)

The rationale behind grafting haploidentical hematopoietic stem cells

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2347673-2347673

2024

Volltextzugriff (PDF)

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

Journal of clinical oncology, 2021-10, Vol.39 (30), p.3328-3339

2021

Volltextzugriff (PDF)

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

Expert opinion on biological therapy, 2024-03, Vol.24 (3), p.139-146

2024

Volltextzugriff (PDF)

Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2021-05, Vol.56 (5), p.1180-1189

2021

Volltextzugriff (PDF)

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Blood, 2010-12, Vol.116 (24), p.5111-5118

2010

Volltextzugriff (PDF)

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4003-4011

2017

Volltextzugriff (PDF)

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738

2010

Volltextzugriff (PDF)

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (17), p.1874

2011

Volltextzugriff (PDF)

Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies

American journal of hematology, 2021-04, Vol.96 (4), p.455-461

2021

Volltextzugriff (PDF)

Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment

Transfusion (Philadelphia, Pa.), 2016-04, Vol.56 (4), p.9S-14S

Maziarz, Richard T.

2016

Volltextzugriff (PDF)

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

Blood, 2009-06, Vol.113 (23), p.5720-5726

2009

Volltextzugriff (PDF)

1 – 25 von 692

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(486)
Mit Volltextzugriff
(636)

Publikationsform

Artikel
(619)
Buchkapitel
(70)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(692)

Erscheinungsjahr

n.n

Thema

Science & Technology
(293)
Life Sciences & Biomedicine
(286)
Humans
(256)
Hematology
(186)
Adult
(146)
Male
(146)
Female
(142)
Middle Aged
(140)
Transplantation
(116)
Immunology
(108)
Aged
(105)
Adolescent
(77)
Hematology, Oncology And Palliative Medicine
(76)
Hematopoietic Stem Cell Transplantation
(71)
Biological And Medical Sciences
(69)
Oncology
(65)
Treatment Outcome
(63)
Hematopoietic Stem Cell Transplantation - Methods
(58)
Transplantation, Homologous
(58)
Medical Sciences
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Clash of the titans: axi-cel versus tisa-cel for advanced-stage DLBCL

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

The rationale behind grafting haploidentical hematopoietic stem cells

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies

Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

Suchergebnisse filtern